The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis

被引:56
作者
Chang, Daniel T. [1 ]
Olivier, Kenneth R. [1 ]
Morris, Christopher G. [1 ]
Liu, Chihray [1 ]
Dempsey, James F. [1 ]
Benda, Rashmi K. [1 ]
Palta, Jatinder R. [1 ]
机构
[1] Univ Florida, Dept Radiat Oncol, Coll Med, Gainesville, FL 32610 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 01期
关键词
treatment outcomes; radiotherapy; radiation pneumonitis; lung neoplasms;
D O I
10.1016/j.ijrobp.2005.09.047
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: To determine if heterogeneity correction significantly affects commonly measured dosimetric parameters predicting pulmonary toxicity in patients receiving radiation for lung cancer. Methods and Materials: Sixty-eight patients treated for lung cancer were evaluated. The conformal treatment technique mostly employed anteroposterior/posterior-anterior fields and off-cord obliques. The percent total lung volume receiving 20 Gy or higher (V-20) and mean lung dose (MLD) were correlated with the incidence of radiation pneumonitis. Parameters from both heterogeneity-corrected and heterogeneity-uncorrected plans were used to assess this risk. Results: Univariate analysis revealed a significant correlation between the development of radiation pneumonitis and both V-20 and MLD. A best-fit line to a plot of V-20 from the homogeneous plan against the corresponding V., heterogeneous value produced a slope of 1.00 and zero offset, indicating no difference between the two parameters. For MLD, a similarly significant correlation is seen between the heterogeneous and homogeneous parameters, indicating a 4% difference when correcting for heterogeneity. A significant correlation was also observed between the MLD and V-20 parameters (p < 0.0001). Conclusions: A high degree of correlation exists between heterogeneity-corrected and heterogeneity-uncorrected dosimetric parameters for lung and the risk of developing pneumonitis. Either V20 or MLD predicts the pneumonitis risk with similar effect. (c) 2006 Elsevier Inc.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 26 条
[1]
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer [J].
Armstrong, J ;
Raben, A ;
Zelefsky, M ;
Burt, M ;
Leibel, S ;
Burman, C ;
Kutcher, G ;
Harrison, L ;
Hahn, C ;
Ginsberg, R ;
Rusch, V ;
Kris, M ;
Fuks, Z .
RADIOTHERAPY AND ONCOLOGY, 1997, 44 (01) :17-22
[2]
Accelerated hypofractionation for early-stage non-small-cell lung cancer [J].
Cheung, PCF ;
Yeung, LTF ;
Basrur, V ;
Ung, YC ;
Balogh, J ;
Danjoux, CE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04) :1014-1023
[3]
Treatment planning for lung cancer: Traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription [J].
Frank, SJ ;
Forster, KM ;
Stevens, CW ;
Cox, JD ;
Komaki, R ;
Liao, ZX ;
Tucker, S ;
Wang, XM ;
Steadham, RE ;
Brooks, C ;
Starkschall, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (05) :1308-1318
[4]
THE CURATIVE TREATMENT BY RADIOTHERAPY ALONE OF STAGE-I NON-SMALL-CELL CARCINOMA OF THE LUNG [J].
GAUDEN, S ;
RAMSAY, J ;
TRIPCONY, L .
CHEST, 1995, 108 (05) :1278-1282
[5]
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [J].
Graham, MV ;
Purdy, JA ;
Emami, B ;
Harms, W ;
Bosch, W ;
Lockett, MA ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02) :323-329
[6]
RESULTS OF RADICAL RADIATION-THERAPY IN CLINICAL STAGE-I, TECHNICALLY OPERABLE NON-SMALL CELL LUNG-CANCER [J].
HAFFTY, BG ;
GOLDBERG, NB ;
GERSTLEY, J ;
FISCHER, DB ;
PESCHEL, RE .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (01) :69-73
[7]
Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer [J].
Hayakawa, K ;
Mitsuhashi, N ;
Saito, Y ;
Nakayama, Y ;
Furuta, M ;
Sakurai, H ;
Kawashima, M ;
Ohno, T ;
Nasu, S ;
Niibe, H .
LUNG CANCER, 1999, 26 (03) :137-142
[8]
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial [J].
Hayman, JA ;
Martel, MK ;
Ten Haken, RK ;
Normolle, DP ;
Todd, RF ;
Littles, JF ;
Sullivan, MA ;
Possert, PW ;
Turrisi, AT ;
Lichter, AS .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :127-136
[9]
Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer [J].
Hernando, ML ;
Marks, LB ;
Bentel, GC ;
Zhou, SM ;
Hollis, D ;
Das, SK ;
Fan, M ;
Munley, MT ;
Shafman, TD ;
Anscher, MS ;
Lind, PA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :650-659
[10]
Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART) [J].
Jenkins, P ;
D'Amico, K ;
Benstead, K ;
Elyan, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (02) :360-366